UPDATE: Oppenheimer Upgrades UnitedHealth Group to Outperform; Valuation is Overly Pessimistic
Oppenheimer upgraded UnitedHealth Group (NYSE: UNH) from Perform to Outperform and raises the price target from $63.00 to $66.00.
Oppenheimer commented, "We believe that UNH's current discounted multiples appear attractive in light of the overly-pessimistic outlook regarding the impact of the ACA, and the recent pull-back related to MA rates. Furthermore, following the Q4:12 earnings conference call, we have increased confidence that FY2013 results will outperform expectations. With strong cash flow, a well-diversified portfolio and a strong track record of performance, we would be buyers of UNH."
UnitedHealth Group closed at $55.21 on Wednesday.
Latest Ratings for UNH
|Mar 2015||Credit Suisse||Maintains||Outperform|
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.